Buscar resultados de ensayos clínicos
Adenoma, Islet Cell - 110 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET Condición: Islet Cell Tumor Fecha: 2011-06-14 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors Condición: Pancreatic Neuroendocrine Tumors Fecha: 2010-05-10 Intervenciones: Drug: Sunitinib Sunitinib capsule will be given orally at continuous daily dosing with a dose of 37.5 mg |
Recruiting |
Nombre del estudio: Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders Condición:
Fecha: 2009-01-27 Intervenciones: |
Terminated |
Nombre del estudio: Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors Condición: Pancreatic Cancer Fecha: 2008-01-24 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors Condición: Pancreatic Neuroendocrine Tumor Fecha: 2007-12-17 Intervenciones:
|
Terminated |
Nombre del estudio: A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors Condición:
Fecha: 2007-01-29 Intervenciones:
|
Recruiting |
Nombre del estudio: Asymptomatic Small Pancreatic Endocrine Neoplasms. Condición: Non Functioning Pancreatic Endocrine Tumor Fecha: 2017-03-06 Intervenciones:
|
Recruiting |
Nombre del estudio: Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors) Condición:
Fecha: 2017-02-02 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs Condición:
|
Active, not recruiting |
Nombre del estudio: Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors Condición:
Fecha: 2016-04-07 Intervenciones:
|